Sakar Healthcare Limited (SAKAR) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.101x

Based on the latest financial reports, Sakar Healthcare Limited (SAKAR) has a cash flow conversion efficiency ratio of 0.101x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs305.87 Million ≈ $3.31 Million USD) by net assets (Rs3.03 Billion ≈ $32.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SAKAR company net worth for the company's overall valuation and market capitalisation.

Sakar Healthcare Limited - Cash Flow Conversion Efficiency Trend (2010–2026)

This chart illustrates how Sakar Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sakar Healthcare Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sakar Healthcare Limited ranked by their cash flow conversion efficiency. Explore SAKAR cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Sportking India Limited NSE:SPORTKING	0.142x
Propel Funeral Partners Ltd AU:PFP	0.059x
Race Oncology Ltd AU:RAC	-0.166x
Palladyne AI Corp NASDAQ:PDYN	-0.143x
Pt Pakuan Tbk JK:UANG	-0.138x
Marine Products Corporation NYSE:MPX	0.077x
Mia Teknoloji AS IS:MIATK	0.025x
Keyfield International Berhad KLSE:5321	0.117x

Annual Cash Flow Conversion Efficiency for Sakar Healthcare Limited (2010–2026)

The table below shows the annual cash flow conversion efficiency of Sakar Healthcare Limited from 2010 to 2026. View SAKAR stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs3.24 Billion ≈ $35.09 Million	Rs393.71 Million ≈ $4.26 Million	0.121x	+1.79%
2025-03-31	Rs2.85 Billion ≈ $30.87 Million	Rs340.32 Million ≈ $3.68 Million	0.119x	+27.82%
2024-03-31	Rs2.62 Billion ≈ $28.37 Million	Rs244.67 Million ≈ $2.65 Million	0.093x	-54.22%
2023-03-31	Rs1.73 Billion ≈ $18.75 Million	Rs353.14 Million ≈ $3.82 Million	0.204x	-27.26%
2022-03-31	Rs1.27 Billion ≈ $13.78 Million	Rs356.99 Million ≈ $3.86 Million	0.280x	+89.16%
2021-03-31	Rs984.52 Million ≈ $10.65 Million	Rs145.77 Million ≈ $1.58 Million	0.148x	+18.92%
2020-03-31	Rs813.20 Million ≈ $8.79 Million	Rs101.25 Million ≈ $1.09 Million	0.125x	-53.27%
2019-03-31	Rs717.04 Million ≈ $7.75 Million	Rs191.03 Million ≈ $2.07 Million	0.266x	+160.56%
2018-03-31	Rs514.93 Million ≈ $5.57 Million	Rs52.65 Million ≈ $569.38K	0.102x	+18606825.53%
2017-03-31	Rs355.03 Million ≈ $3.84 Million	Rs195.09 ≈ $2.11	0.000x	-88.53%
2016-03-31	Rs191.82 Million ≈ $2.07 Million	Rs918.64 ≈ $9.93	0.000x	-100.00%
2015-03-31	Rs148.28 Million ≈ $1.60 Million	Rs41.76 Million ≈ $451.59K	0.282x	-54.40%
2014-03-31	Rs138.71 Million ≈ $1.50 Million	Rs85.67 Million ≈ $926.46K	0.618x	+13.02%
2013-03-31	Rs121.19 Million ≈ $1.31 Million	Rs66.23 Million ≈ $716.22K	0.546x	+160.66%
2012-03-31	Rs137.59 Million ≈ $1.49 Million	Rs28.84 Million ≈ $311.95K	0.210x	+1.82%
2011-03-31	Rs132.75 Million ≈ $1.44 Million	Rs27.33 Million ≈ $295.59K	0.206x	+2334.89%
2010-03-31	Rs123.53 Million ≈ $1.34 Million	Rs-1.14 Million ≈ $-12.31K	-0.009x	--

About Sakar Healthcare Limited

NSE:SAKAR India Drug Manufacturers - Specialty & Generic

Market Cap

$280.06 Million

Rs25.90 Billion INR

Market Cap Rank

#15248 Global

#767 in India

Share Price

Rs1179.80

Change (1 day)

+4.45%

52-Week Range

Rs346.45 - Rs1179.80

All Time High

Rs1179.80